Total submissions: 1
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Gene |
RCV000200022 | SCV000250021 | uncertain significance | not provided | 2016-06-17 | criteria provided, single submitter | clinical testing | The P1217R variant has not been published as a mutation, nor has it been reported as a benign polymorphism to our knowledge. The P1217R variant was not observed in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The P1217R variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved among mammals and in silico analysis predicts this variant is probably damaging to the protein structure/function. However, only one missense mutation in a nearby residue (G1209R) has been reported in the Human Gene Mutation Database in association with Ehlers-Danlos syndrome (Stenson et al., 2014), indicating this region of the protein may be tolerant of change. Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic mutation or a rare benign variant. |